Blood test markers for new blood cancers and hepatitis
Part of Blood & lymphatic clinical trials.
This study looks at blood test results (called cell population data) to see if they can help doctors better understand or diagnose chronic lymphoproliferative disorders (types of blood cancer) and viral hepatitis (liver infection). The goal is to find simple, early clues that might make diagnosis faster or easier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must be newly diagnosed with a chronic lymphoproliferative disorder (a type of blood cancer, like certain leukemias or lymphomas).
- You must also be newly diagnosed with viral hepatitis (a liver infection caused by a virus).
- You must not be receiving treatment for your blood disorder or hepatitis yet.
- You must not have any other blood disease or chronic condition that could affect blood test results.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at certain markers on your blood cancer cells to understand them better. By joining, you help doctors learn more about your disease, which may guide future care.
This study follows people newly diagnosed with chronic lymphocytic leukemia (CLL), a type of blood cancer, to learn more about the disease and how it progresses. By participating, you help researchers understand CLL better, which may improve future treatments.
This study looks at routine blood test results (called CBC) in people who have just been diagnosed with acute lymphoblastic leukemia (ALL), a type of blood cancer. The goal is to see if certain blood levels can help doctors understand the disease better and guide treatment.
This study collects information from patients with lymphoproliferative disorders—conditions affecting blood and lymph cells—to help doctors better understand these diseases and improve care. Your medical records and information may be used to support research that could benefit future patients.
This study looks at two simple blood tests in people newly diagnosed with ALL (a type of blood cancer) to see if these tests can help predict how the disease might progress. It may help doctors understand your condition better and could lead to more personalized care.
This study is looking for a better way to diagnose and track chronic liver disease without invasive procedures like biopsies. If you join, researchers will use simple tests (like blood tests or imaging) to see how well they predict the progression of your liver condition.
Hear when a new Chronic Lymphoproliferative Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.